News
& Events
News
& Events

News
& Events

Inversago Pharma to participate in Life Science companies and investors networking event organized by Torys

MONTREAL (CANADA) – April 29, 2022 – Inversago Pharma Inc., a clinical stage biotech company with a unique portfolio of CB1 inverse agonists, today announced that François Ravenelle, PhD, Chief Executive Officer, will take part to one-on-one meetings with investors during Torys’ Life Science networking event. The event will take place on Sunday, May 1, […]

Read more

Inversago Pharma to participate in Morgan Stanley Private Company Biotech Corporate Access Day

MONTREAL (CANADA) – April 29, 2022 – Inversago Pharma Inc. , a clinical stage biotech company with a unique portfolio of CB1 inverse agonists, today announced that François Ravenelle, PhD, Chief Executive Officer, will take part to one-on-one meetings with investors during the Morgan Stanley Private Company Biotech Corporate Access Day. This day-long event will […]

Read more

Inversago Pharma to present at upcoming Bloom Burton & Co. Healthcare Investor Conference to be held on May 2-3, 2022 in Toronto, ON

MONTREAL (CANADA) – April 11, 2022 – Inversago Pharma Inc. (“Inversago”), a clinical stage biotech company with a unique portfolio of CB1 inverse agonists, today announced that François Ravenelle, PhD, Chief Executive Officer, will be presenting at the Bloom Burton & Co. Healthcare Investor Conference. Details are as follows: Conference Dates: Monday, May 2 and […]

Read more

Inversago Pharma Announces Dosing of First Participant with Metabolic Syndrome in Phase 1B Clinical Trial

MONTREAL (CANADA) – March 15, 2022 – Inversago Pharma Inc. (“Inversago”), a clinical stage biotech company with a unique portfolio of CB1 inverse agonists, announced today the dosing of the first participant with metabolic syndrome in a Phase 1b clinical trial. This 28-day trial will test the pharmacokinetics and safety profile of Inversago’s lead molecule, […]

Read more